Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Pizzo
Observed names:
B Pizzo,
B. Pizzo,
PIZZO, BARBARA,
Pizzo B,
Pizzo Barbara,
Pizzo, Barbara
show all 6
Institution:
Sapienza University of Rome
Observed institutions:
Memorial Sloan Kettering Cancer Center,
Vanderbilt University,
University of Ferrara,
Cornell University,
Sanofi (United States),
Weill Cornell Medicine,
Vanderbilt-Ingram Cancer Center,
University of Florence,
Sapienza University of Rome
show all 9
ORCID:
0000-0002-4152-1430
Observed ORCID:
0000-0002-4152-1430
OpenAlex ID:
A5003980612
Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
2004
·
Vincent A. Miller
, Mark G. Kris
, et al.
·
Journal of Clinical Oncology
·
757
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein: A Phase II clinical trial
2005
·
Lee M. Krug
, John P. Crapanzano
, et al.
·
Cancer
·
165
Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin
2004
·
Lee M. Krug
, Govind Ragupathi
, et al.
·
Clinical Cancer Research
·
133
Vaccination of Small Cell Lung Cancer Patients with Polysialic Acid orN-Propionylated Polysialic Acid Conjugated to Keyhole Limpet Hemocyanin
2004
·
Lee M. Krug
, Govind Ragupathi
, et al.
·
Clinical Cancer Research
·
130
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer
2007
·
Daniel T. Milton
, Gregory J. Riely
, et al.
·
Cancer
·
100
PDF
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma
2005
·
Lee M. Krug
, Vincent A. Miller
, et al.
·
Cancer
·
90
PDF
Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC)
2004
·
M. G. Kris
, A. Sandler
, et al.
·
Journal of Clinical Oncology
·
77
Pilot Trial of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib Plus Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non–Small-Cell Lung Cancer
2003
·
Vincent A. Miller
, David H. Johnson
, et al.
·
Journal of Clinical Oncology
·
64
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer
1997
·
V.A. Miller
, K.K. Ng
, et al.
·
Annals of Oncology
·
62
Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer
2000
·
Vincent A. Miller
, Lee M. Krug
, et al.
·
Journal of Clinical Oncology
·
59
Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
1998
·
M J Nolte
, R Berkery
, et al.
·
Journal of Clinical Oncology
·
55
10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.
2003
·
Lee M Krug
, Christopher G Azzoli
, et al.
·
PubMed
·
53
Determinants of sustainable mode choice in different socio-cultural contexts: A comparison of Rome and San Francisco
2018
·
Samira Ramezani
, Barbara Pizzo
, et al.
·
International Journal of Sustainable Transportation
·
32
A Phase 1 Study of Pralatrexate in Combination with Paclitaxel or Docetaxel in Patients with Advanced Solid Tumors
2007
·
Christopher G. Azzoli
, Lee M. Krug
, et al.
·
Clinical Cancer Research
·
32
Phase I/II trial of gefitinib and RAD001 (everolimus) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
2005
·
D. T. Milton
, M. G. Kris
, et al.
·
Journal of Clinical Oncology
·
25
O-188 Encouraging activity and durable responses demonstrated by the epithelial growth factor receptor-tyrosine kinase inhibitor, Erlotinib (Tarceva TM, OSI774), in patients with advanced bronchioloalveolar (BAC) cell carcinoma
2003
·
Jyoti D. Patel
, Vincent A. Miller
, et al.
·
Lung Cancer
·
22
54 The epidermal growth factor receptor tyrosine kinase inhibitor, eriotinib (Tarceva TM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: interim results of a phase II trial
2003
·
J. Patel
, V. Miller
, et al.
·
European Journal of Cancer Supplements
·
14
Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma
2000
·
Vincent A. Miller
, Kenneth K. Ng
, et al.
·
Cancer
·
12
PDF
Bone Marrow Transplantation: a Lifesaving Option
1984
·
Ruth Nuscher
, Lorraine Baltzer
, et al.
·
AJN American Journal of Nursing
·
12
A Phase II Tolerability Study of Cisplatin Plus Docetaxel as Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer
2007
·
Christopher G. Azzoli
, Lee M. Krug
, et al.
·
Journal of Thoracic Oncology
·
11
PDF
The Political Economy of a Collusive Urban Regime: Making Sense of Urban Development Projects in Rome
2021
·
Esposito, Edoardo
, Moini, Giulio
, et al.
·
PARTECIPAZIONE E CONFLITTO
·
6
PDF
Earthquakes, public spaces and (the social construction of) environmental disasters. The role of public space for risk mitigation and urban redevelopment and the role of environmental disasters for re assessing the ‘space of the Public’.
2013
·
Barbara Pizzo
, Giacomina Di Salvo
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
6
C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial
2004
·
L. M. Krug
, J. P. Crapanzano
, et al.
·
Journal of Clinical Oncology
·
6
Rendita e metropolizzazione. Il caso di Roma
2021
·
Barbara Pizzo
·
ARCHIVIO DI STUDI URBANI E REGIONALI
·
5
An historical and critical reconstruction of disciplines and interdisciplinarity in urban studies
2019
·
Pizzo, Barbara
, Gribat, Nina
, et al.
·
Tracce urbane. Rivista italiana transdisciplinare di studi urbani
·
5
PDF
Show more works
View as search
Works count:
60
Citation count:
2,012
H-index:
16
I10-index:
20
Year
Topic
Type